Moreover, inhibition of NLRP3 can significantly inhibit amyloidosis and neuropathy and ameliorate cognitive behavior impairment in AD (Heneka et al., 2013; Dempsey et al., 2017). This evidence concerns the gene NLRP3 and Alzheimer disease.